Otonomy to Report Third Quarter 2017 Financial Results and Provide Corporate Update
November 01 2017 - 4:05PM
Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company
focused on the development and commercialization of innovative
therapeutics for diseases and disorders of the ear, today announced
it will report financial results for the third quarter 2017 as well
as provide a corporate update at 4:30 p.m. EST on November 8, 2017.
The live call may be accessed by dialing (877) 305-6769 for
domestic callers and (678) 562-4239 for international callers with
conference ID code number: 4495749. A live webcast of the call will
be available online in the investor relations section of Otonomy’s
website at www.otonomy.com and will be archived there for 30
days.
About Otonomy
Otonomy is a biopharmaceutical company focused on the
development and commercialization of innovative therapeutics for
diseases and disorders of the ear. OTIPRIO® (ciprofloxacin otic
suspension) is approved in the United States for use during
tympanostomy tube placement surgery in pediatric patients, an sNDA
has been accepted for filing by the FDA for acute otitis externa
(AOE) and a successful End-of-Phase 2 review has been completed
with the FDA for acute otitis media with tympanostomy tubes (AOMT).
OTIVIDEX™ is a sustained-exposure formulation of the steroid
dexamethasone. OTO-311 is an NMDA receptor antagonist for the
treatment of tinnitus that has completed a Phase 1 clinical safety
trial. A set of programs targeting sensorineural hearing loss
including age-related hearing loss are in preclinical development.
Otonomy’s proprietary formulation technology utilizes a
thermosensitive gel and drug microparticles to enable single dose
treatment by a physician. For additional information please visit
www.otonomy.com.
Contacts:Media InquiriesCanale
CommunicationsHeidi Chokeir, Ph.D.Senior Vice
President619.849.5377heidi@canalecomm.com
Investor InquiriesWestwicke PartnersRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024